An agent that blocks tumor angiogenesis, growth, and metastasis without affecting normal tissues -- whether used alone or in combination with currently approved drugs -- would change the way we treat cancer. In this issue, Fischer et al. (2007) offer compelling evidence that a monoclonal antibody against placental growth factor (PlGF), a member of the VEGF family, has such potential in mice.
alphaPlGF: a new kid on the antiangiogenesis block. Publishing Authors By Initials
alphaPlGF: a new kid on the antiangiogenesis block. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Cell
VOLUME: 131
Page Numbers: 443-5
Journal Abbreviation: Cell
ISSN: 0092-8674
DAY: 2
MONTH: Nov
YEAR: 2007
alphaPlGF: a new kid on the antiangiogenesis block. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 413066
alphaPlGF: a new kid on the antiangiogenesis block. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: alphaPlGF: a new kid on the antiangiogenesis block. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for alphaPlGF: a new kid on the antiangiogenesis block.
AFFILIATION: Steele Lab of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. jain@steele.mgh.harvard.edu
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Cell
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
alphaPlGF: a new kid on the antiangiogenesis block Related Publications